OPKO HEALTH, INC. (OPK)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Revenues | 156,807 | 149,952 | 173,632 | 182,186 |
| Cost of goods and services sold | - | 107,332 | 133,503 | 130,533 |
| Selling, general and administrative | 59,597 | 59,086 | 98,203 | 68,821 |
| Research and development | 30,342 | 30,841 | 28,770 | 24,082 |
| Cost of goods and services sold-Service | 82,383 | - | - | - |
| Cost of goods and services sold-Product | 25,022 | - | - | - |
| Amortization of intangible assets | 19,444 | 19,861 | 20,433 | 20,420 |
| Total costs and expenses | 216,788 | 217,120 | - | - |
| Us-gaap_disposalgroupnotdiscontinuedoperationgainlossondisposal | - | - | 121,493 | - |
| Us-gaap_operatingexpenses | - | - | 159,416 | 243,856 |
| Operating loss | -59,981 | -67,168 | 14,216 | -61,670 |
| Other Nonoperating Income Expense | -35,515 | 4,852 | 48,636 | 58,874 |
| Interest income | 3,287 | 4,681 | 2,928 | 391 |
| Interest expense | 70,327 | 15,466 | 17,359 | 8,180 |
| Fair value changes of derivative instruments, net | 16 | -273 | -1 | 1 |
| Other (expense) income, net | -102,539 | -6,206 | 34,204 | 51,086 |
| Loss before income taxes and investment losses | -162,520 | -73,374 | 48,420 | -10,584 |
| Income tax benefit | -14,079 | -5,770 | 23,527 | -280 |
| Net loss before investment losses | -148,441 | -67,604 | 24,893 | -10,304 |
| Loss from investments in investees | - | -9 | -3 | -1 |
| Net loss | -148,441 | -67,613 | 24,890 | -10,305 |
| Loss per share, basic | -0.19 | -0.1 | 0.04 | -0.01 |
| Loss per share, diluted | -0.19 | - | 0.03 | - |
| Weighted average common shares outstanding, basic | 788,006,992 | 671,577,429 | 694,622,466 | 697,211,592 |
| Weighted average common shares outstanding, diluted | 788,006,992 | - | 998,363,636 | - |